Critical Survey: Pixie Dust Technologies (NASDAQ:PXDT) and Yubo International Biotech (OTCMKTS:YBGJ)

Yubo International Biotech (OTCMKTS:YBGJ) and Pixie Dust Technologies (NASDAQ:PXDT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, valuation, dividends, profitability and analyst recommendations.

Earnings and Valuation

This table compares Yubo International Biotech and Pixie Dust Technologies”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yubo International Biotech	$610,000.00	9.69	-$1.20 million	($0.01)	-5.00
Pixie Dust Technologies	$993.02 million	0.01	-$12.53 million	N/A	N/A

Yubo International Biotech has higher earnings, but lower revenue than Pixie Dust Technologies.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Yubo International Biotech and Pixie Dust Technologies, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Yubo International Biotech	0	0	0	0	0.00
Pixie Dust Technologies	0	0	1	0	3.00

Pixie Dust Technologies has a consensus target price of $5.21, indicating a potential upside of 798.28%. Given Pixie Dust Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe Pixie Dust Technologies is more favorable than Yubo International Biotech.

Profitability

This table compares Yubo International Biotech and Pixie Dust Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Yubo International Biotech	-274.96%	N/A	-121.41%
Pixie Dust Technologies	N/A	N/A	N/A

Risk & Volatility

Yubo International Biotech has a beta of 2.99, suggesting that its stock price is 199% more volatile than the S&P 500. Comparatively, Pixie Dust Technologies has a beta of -0.25, suggesting that its stock price is 125% less volatile than the S&P 500.

Insider and Institutional Ownership

0.4% of Pixie Dust Technologies shares are owned by institutional investors. 56.5% of Yubo International Biotech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Pixie Dust Technologies beats Yubo International Biotech on 7 of the 11 factors compared between the two stocks.

About Yubo International Biotech

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.

About Pixie Dust Technologies

Pixie Dust Technologies, Inc., a technology company, focuses on personal care and diversity, and workspace and digital transformation businesses primarily in Japan. It offers SonoRepro, an ultrasonic non-contact vibrotactile stimulation scalp care device; VUEVO, a series of directional voice arrival detection devices for individuals with deaf and hard-of-hearing; and kikippa, an acoustic stimulation device functioning as a desk-top speaker. The company also provides iwasemi, a sound-absorbing or sound-proofing material for architectural and interior design firms; hackke, a location positioning technology; KOTOWARI, a technology offering spatial analysis data; and magickiri, a planning services and monitoring service, which monitors human behavior and analyzes the customer's environment on the customer's behalf. In addition, it operates Pixie Nest, a membership forum, which hosts meetings and distributes information to facilitate solving social issues. The company was incorporated in 2017 and is headquartered in Tokyo, Japan.